National Proceedings: CTEPH 2017 will provide a multidisciplinary overview of the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). The contemporary approach to the diagnosis of CTEPH, the role of pulmonary hypertension targeted medical therapy, balloon pulmonary angioplasty in the management of CTEPH, and the latest in surgical advancements will be highlighted topics of this conference. The epidemiology of chronic thromboembolic disease in the United States, as well as the pathophysiology and genetics of CTEPH, will be featured lectures. The conference format will be comprised of didactic presentations, debates, and panel discussions involving national and international experts in the field. The agenda has been developed to encourage audience participation throughout the symposium. As has been the case in previous National Proceedings, there will be the opportunity for attendees to submit and present scientific abstracts and unique clinical cases related to CTEPH and chronic thromboembolic pulmonary vascular disease.
At the conclusion of this activity, participants should be able to:
- • Discuss an updated understanding of the epidemiology and pathophysiology of CTEPH;
- • Utilize the latest diagnostic modalities and evaluative approach to patients with suspected chronic thromboembolic disease;
- • Illustrate the advancements in the surgical procedure, pulmonary thromboendarterectomy, currently available for patients with chronic thromboembolic disease and CTEPH;
- • Recognize the evolving role of balloon pulmonary angioplasty in the management of CTEPH;
- • Define the role of pulmonary hypertension targeted medical therapy in selected patient groups with chronic thromboembolic pulmonary hypertension.
This program has been designed to provide internists, pulmonologists, cardiologists, cardiovascular surgeons, anesthesiologists, registered nurses, and allied healthcare professionals with state-of-the-art information to evaluate and manage patients with chronic thromboembolic pulmonary hypertension.